Skip to main content
Log in

A New Standard of Care? Standard Dose Sofosbuvir in an HCV-Infected Liver Transplant Recipient Undergoing Hemodialysis

  • Stanford Multidisciplinary Seminars
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Perumpail RB, Wong RJ, Ha LD, et al. Sofosbuvir and simeprevir combination therapy in the setting of liver transplantation and hemodialysis. Transpl Infect Dis. 2015;17:275–278.

    Article  PubMed  CAS  Google Scholar 

  2. Lawitz E, Mangia A, Wyles D, et al. Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med. 2013;368:1878–1887.

    Article  PubMed  CAS  Google Scholar 

  3. Cornpropst M, Denning J, Clemons D, et al. The effect of renal impairment and end stage renal disease on the single-dose pharmacokinetics of GS-7977 [Abstract]. In: Abstracts of the International Liver Congress 2012—47th Annual Meeting of the European Association for the Study of Liver, Barcelona, Spain, April 18–22, 2012.

  4. Lawitz E, Sulkowski MS, Ghalib R, et al. Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naïve patients: the COSMOS randomized study. Lancet. 2014;384:1756–1765.

    Article  PubMed  CAS  Google Scholar 

  5. U.S. Food and Drug Administration. SOVALDI. 2013. http://www.accessdata.fda.gov/spl/data/b0de1fcd-6d03-4a91-a7df-72a14c8bc7d0/b0de1fcd-6d03-4a91-a7df-72a14c8bc7d0.xml. Accessed May 30, 2014.

  6. U.S. Food and Drug Administration. OLYSIO. 2013. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/205123s001lbl.pdf. Accessed May 30, 2014.

  7. American Association for the Study of Liver Diseases and Infectious Diseases Society of America. Recommendations for testing, managing, and treating hepatitis C. 2014. http://www.hcvguidelines.org/full-report-view. Accessed May 30, 2014.

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aijaz Ahmed.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Perumpail, R.B., Wong, R.J., Pham, E.A. et al. A New Standard of Care? Standard Dose Sofosbuvir in an HCV-Infected Liver Transplant Recipient Undergoing Hemodialysis. Dig Dis Sci 61, 39–41 (2016). https://doi.org/10.1007/s10620-015-3756-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-015-3756-z

Keywords

Navigation